| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Net revenues | ||||||
116,251 | 135,665 | |||||
Cost of revenues | ||||||
81,742 | 87,576 | |||||
Gross profit | ||||||
34,509 | 48,089 | |||||
Operating expenses: | ||||||
Research and development | ||||||
26,064 | 23,247 | |||||
Sales and marketing | ||||||
13,908 | 12,228 | |||||
General and administrative | ||||||
16,182 | 7,220 | |||||
Restructuring costs | ||||||
736 | - | |||||
Total operating expenses | ||||||
56,890 | 42,695 | |||||
Loss from operations | ||||||
-22,381 | 5,394 | |||||
Interest expense | ||||||
-1,522 | -1,828 | |||||
Change in fair value of warrant liability | ||||||
0 | 970 | |||||
Other expense, net | ||||||
-543 | -565 | |||||
Loss before income taxes | ||||||
-24,446 | 2,031 | |||||
Income tax expense | ||||||
1,388 | 754 | |||||
Net loss | ||||||
-25,834 | 1,277 | |||||
Dividends on Series A, Series A-1 and Series A-2 preferred stock | ||||||
- | 10,152 | |||||
Net loss attributable to common stockholders | ||||||
-25,834 | -8,875 | |||||
Net loss per share, basic and diluted | ||||||
-1.39 | -2.57 | |||||
Weighted–average shares used in computing net loss per share attributable to common stockholders, basic and diluted | ||||||
18,603 | 3,447 | |||||